BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25651924)

  • 1. Skin and mucosal human papillomavirus seroprevalence in persons with Fanconi Anemia.
    Katzenellenbogen RA; Carter JJ; Stern JE; Butsch Kovacic MS; Mehta PA; Sauter SL; Galloway DA; Winer RL
    Clin Vaccine Immunol; 2015 Apr; 22(4):413-20. PubMed ID: 25651924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.
    Mehta PA; Sauter S; Zhang X; Davies SM; Wells SI; Myers KC; Panicker G; Unger ER; Butsch Kovacic M
    Vaccine; 2017 Dec; 35(48 Pt B):6712-6719. PubMed ID: 29042204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study.
    Zhang C; Liu F; Deng Q; He Z; Xi L; Liu Y; Pan Y; Ning T; Guo C; Xu R; Zhang L; Cai H; Ke Y
    Sex Transm Infect; 2015 Nov; 91(7):506-9. PubMed ID: 25999521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.
    Ortiz AP; Tortolero-Luna G; Romaguera J; Pérez CM; González D; Muñoz C; González L; Marrero E; Suárez E; Palefsky JM; Panicker G; Unger ER
    Papillomavirus Res; 2018 Jun; 5():109-113. PubMed ID: 29555601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.
    Ji J; Sun HK; Smith JS; Wang H; Esser MT; Hu S; Pretorius RG; Chen W; Belinson JL; Qiao YL
    BMC Infect Dis; 2012 Jun; 12():137. PubMed ID: 22715915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence and risk factors for human papillomavirus in Taiwan.
    Wang IJ; Viscidi R; Hwang KC; Lin TY; Chen CJ; Huang LM; Chen HH; Chen CJ
    J Trop Pediatr; 2008 Feb; 54(1):14-8. PubMed ID: 17984124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program.
    Učakar V; Jelen MM; Faust H; Poljak M; Dillner J; Klavs I
    Vaccine; 2013 Oct; 31(43):4935-9. PubMed ID: 23994822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands.
    Vos RA; Pasmans H; Tymchenko L; Janga-Jansen AVA; Baboe-Kalpoe S; Hulshof K; de Melker HE; van der Klis FRM
    Vaccine; 2020 Mar; 38(13):2816-2826. PubMed ID: 32088019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of seven high-risk HPV types in The Netherlands.
    Scherpenisse M; Mollers M; Schepp RM; Boot HJ; de Melker HE; Meijer CJ; Berbers GA; van der Klis FR
    Vaccine; 2012 Oct; 30(47):6686-93. PubMed ID: 22959981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran, Iran.
    Aghakhani A; Mamishi S; Sabeti S; Bidari-Zerehpoosh F; Banifazl M; Bavand A; Ramezani A
    Med Microbiol Immunol; 2017 Apr; 206(2):105-110. PubMed ID: 27858157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination.
    Chen CJ; Viscidi RP; Chuang CH; Huang YC; Chiu CH; Lin TY
    J Clin Virol; 2007 Feb; 38(2):126-30. PubMed ID: 17210269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.
    Iannacone MR; Michael KM; Giuliano AR; Waterboer T; Pawlita M; Rollison DE
    J Infect Dis; 2010 Mar; 201(5):760-9. PubMed ID: 20105078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of human papillomavirus antibodies in males and females in England.
    Desai S; Chapman R; Jit M; Nichols T; Borrow R; Wilding M; Linford C; Lowndes CM; Nardone A; Pebody R; Soldan K
    Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.
    Markowitz LE; Sternberg M; Dunne EF; McQuillan G; Unger ER
    J Infect Dis; 2009 Oct; 200(7):1059-67. PubMed ID: 19719390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women.
    Ermel AC; Shew ML; Weaver BA; Qadadri B; Denski C; Tu W; Tong Y; Fortenberry JD; Brown DR
    Sex Transm Infect; 2014 Feb; 90(1):64-9. PubMed ID: 24031030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.
    Nicol AF; Grinsztejn B; Friedman RK; Veloso VG; Cunha CB; Georg I; Pilotto JH; Moreira RI; Castro CA; Silver B; Viscidi RP
    J Clin Virol; 2013 Jun; 57(2):147-51. PubMed ID: 23490398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany - Results from a nationwide population-based survey.
    Loenenbach AD; Poethko-Müller C; Pawlita M; Thamm M; Harder T; Waterboer T; Schröter J; Deleré Y; Wichmann O; Wiese-Posselt M
    Int J Infect Dis; 2019 Jun; 83():3-11. PubMed ID: 30904676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.
    Scherpenisse M; Mollers M; Schepp RM; Boot HJ; Meijer CJ; Berbers GA; van der Klis FR; de Melker HE
    PLoS One; 2012; 7(11):e48807. PubMed ID: 23152809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
    Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
    Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.